Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -301,743 | -264,197 | -191,493 | -118,793 | 49,271 |
| Depreciation Amortization | -8,952 | -7,321 | -5,237 | -2,267 | -8,852 |
| Accounts receivable | 39,602 | 38,319 | 35,958 | 19,698 | -24,744 |
| Accounts payable and accrued liabilities | -19,102 | -20,574 | -17,087 | -652 | 15,882 |
| Other Working Capital | -45,831 | -19,128 | -8,531 | 164 | -65,661 |
| Other Operating Activity | 168,379 | 164,262 | 119,321 | 101,361 | 46,023 |
| Operating Cash Flow | $-167,647 | $-108,639 | $-67,069 | $-489 | $11,919 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 112,014 | 47,014 | -27,986 | 886 | 93,294 |
| PPE Investments | -36,360 | -36,340 | -156 | -67 | -1,241 |
| Investing Cash Flow | $75,654 | $10,674 | $-28,142 | $819 | $92,053 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,132 | 1,984 | 1,493 | 1,446 | 6,858 |
| Other Financing Activity | -1,784 | -1,746 | -1,335 | -1,315 | -3,315 |
| Financing Cash Flow | $348 | $238 | $158 | $131 | $3,543 |
| Exchange Rate Effect | -438 | 87 | -149 | -110 | 160 |
| Beginning Cash Position | 170,920 | 170,920 | 170,920 | 170,920 | 63,245 |
| End Cash Position | 78,837 | 73,280 | 75,718 | 171,271 | 170,920 |
| Net Cash Flow | $-92,083 | $-97,640 | $-95,202 | $351 | $107,675 |
| Free Cash Flow | |||||
| Operating Cash Flow | -167,647 | -108,639 | -67,069 | -489 | 11,919 |
| Capital Expenditure | -36,360 | -36,340 | -156 | -67 | -1,241 |
| Free Cash Flow | -204,007 | -144,979 | -67,225 | -556 | 10,678 |